Literature DB >> 26039637

Stem cell, CRISPR and HIV.

Hsin-Kai Liao1, Mo Li, Llanos Martinez Martinez, Juan Carlos Izpisua Belmonte.   

Abstract

Mesh：

Year:  2015        PMID： 26039637      PMCID： PMC4615082          DOI： 10.1080/15384101.2015.1046791

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

1.  RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

Authors:  Wenhui Hu; Rafal Kaminski; Fan Yang; Yonggang Zhang; Laura Cosentino; Fang Li; Biao Luo; David Alvarez-Carbonell; Yoelvis Garcia-Mesa; Jonathan Karn; Xianming Mo; Kamel Khalili
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

Review 2.  A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV.

Authors:  Mohamed Abou-El-Enein; Gerhard Bauer; Petra Reinke; Matthias Renner; Christian K Schneider
Journal:  Trends Mol Med       Date:  2014-09-25       Impact factor: 11.951

3.  Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells.

Authors:  Hsin-Kai Liao; Ying Gu; Arturo Diaz; John Marlett; Yuta Takahashi; Mo Li; Keiichiro Suzuki; Ruo Xu; Tomoaki Hishida; Chan-Jung Chang; Concepcion Rodriguez Esteban; John Young; Juan Carlos Izpisua Belmonte
Journal:  Nat Commun       Date:  2015-03-10       Impact factor: 14.919

4.  Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.

Authors:  Nathalia Holt; Jianbin Wang; Kenneth Kim; Geoffrey Friedman; Xingchao Wang; Vanessa Taupin; Gay M Crooks; Donald B Kohn; Philip D Gregory; Michael C Holmes; Paula M Cannon
Journal:  Nat Biotechnol       Date:  2010-07-02       Impact factor: 54.908

5.  CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection.

Authors:  Weiming Wang; Chaobaihui Ye; Jingjing Liu; Di Zhang; Jason T Kimata; Paul Zhou
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

6.  Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus.

Authors:  Hirotaka Ebina; Naoko Misawa; Yuka Kanemura; Yoshio Koyanagi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379
  6 in total
  2 in total

Review 1.  Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.

Authors:  Man Teng; Yongxiu Yao; Venugopal Nair; Jun Luo
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 2.  Genome Editing Technologies as Cellular Defense Against Viral Pathogens.

Authors:  Yingzi Zhang; Mo Li
Journal:  Front Cell Dev Biol       Date:  2021-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.